YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

A comparative Analysis of Perception of Health Professionals and Pharmaceutical Companies on the Positive List System

선별등재 제도에 대한 전문가와 제약회사의 인식도 비교분석

  • Ha, Dong-Mun (Korea Institute for Pharmaceutical Policy Affairs) ;
  • Lee, Su-Kyoung (Korea Institute for Pharmaceutical Policy Affairs) ;
  • Kim, Dae-Up (College of Pharmacy, SungKyunKwan University) ;
  • Chung, Kyu-Hyuck (College of Pharmacy, SungKyunKwan University) ;
  • Lee, Eui-Kyung (Graduate School of Clinical Pharmacy, Sookmyung Women's University)
  • Received : 2010.05.03
  • Accepted : 2010.07.21
  • Published : 2010.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

The Positive List System was newly introduced in South Korea as of January 2007. This study aims to survey and compare perception of and attitudes toward the Positive List System in the process of new drug listing that health professionals and pharmaceutical companies have. 50 professionals and 52 companies answered the questionnaire regarding health policy environments, policy decision/enforcement process, policy effects and satisfaction related to introducing the Positive List System. SAS 9.1 was used for statistical analyses. The results showed that participants had the general sympathy with health policy environments for the introduction of the Positive List System into South Korea. However, the response rates of policy decision/enforcement process and effects were negative and these tendencies were more striking in pharmaceutical companies. As for policy satisfaction, participants marked positive responses more than negative ones. It is necessary to remedy and supplement problems with policy decision/enforcement policy and effects revealed in this study and to improve the Positive List System through gathering opinions among groups and organization concerned.

Keywords

References

  1. 보건복지부 : 약제비적정화방안 (2006).
  2. 이의경, 박은자, 박세정, 이태진, 이용갑 : 선별목록(Positive List) 중심의 보험의약품 등재관리제도 개선방안 연구 (2005).
  3. Bae, E. Y., Lee, E. K., et al. : Pharmacoeconomic guidelines and their implementation in the positive list system in south Korea. Value in Health 12(3), 36 (2009).
  4. 국민건강보험공단 : 약가협상지침 (2006).
  5. 이태진 : 약물경제성평가 현황과 제도 도입방안, 보건사회연구원 (2003).
  6. 배은영, 최상은, 김정희 : 의약품 보험급여제도에서 경제성평가자 료의 활용방안, 건강보험심사평가원 (2005).
  7. 방구연 : 의약품 선별등재제도에 관한 실증적 연구. 중앙대학교 산업경영대학원 (2006).
  8. 장경원 : 의약품 선별목록제에 대한 제약회사 보험약가 담당자의 인식도 조사분석, 성균관대학교 임상약학대학원 석사학위논문 (2007).
  9. Yang, B. M., Bae, E. Y., Kim, J. H. et al. : Economic evaluation and pharmaceutical reimbursement reform in south Korea's National Health Insurance 27(1), 179 (2008).
  10. Naylor, C. D., Williams, J. I., Basinski, A., et al. : Technology assessment and cost-effectiveness analysis: misguidelines? CMAJ 148, 921 (1993).
  11. 김진현 : 건강보험 급여의약품 목록정비사업, 한국보건의료기술평가학회 (2008).
  12. 김동윤 : 고령자 주거정책 효과분석에 관한 연구. 경원대학교 대학원. 박사학위 논문 (2008).